AEYE - Risk

Elevated Business & Solvency Risk

Caution: In addition to price volatility, there are balance sheet risks due to higher debt or weaker liquidity (Health Score: 35/100).

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score

7/7 Very High

7 / 7 SRI Price Fluctuation & Beta

Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves noticeably less than the broader market (0.8x).

Beta (Market Relation)

0.84x

Defensive

Volatility (5Y p.a.)

82.7% p.a.

5-Year Horizon

Max Drawdown (5Y)

-84.0%

5-Year Horizon

Sharpe Ratio

-0.13

Return / Risk

Speculative / High Risk: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

High Volatility

Timeframe	Volatility (p.a.)	Max Drawdown	Sharpe Ratio	Return (p.a.)
1 Year	—	—	—	-53.1%
3 Years	83.2%	-84.0%	0.08	+9.6%
5 Years	82.7%	-84.0%	-0.13	-8.1%
10 Years	102.9%	-92.8%	0.04	+6.9%

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Critical leverage: Debt-to-Equity is at 519%.

Unprofitable business model: The company is currently generating net losses.

🔴 Low analyst coverage – higher uncertainty in growth estimates & projections

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (82.7% p.a.).

Historical Stress Test: Maximum peak-to-trough drawdown of -92.8% in the extended horizon.

Corporate Governance & ISS Scores

Shareholder rights, board structure and audit safety (Scale 1 = Low Risk, 10 = High Risk)

Overall Governance Risk

6 ISS Score: 6 / 10

Audit Risk

3 ISS Score: 3 / 10

Board Risk

5 ISS Score: 5 / 10

Short Ratio

1.79